Trending News Today: Mylan Defends EpiPen Price Increase

Top news of the day from across the healthcare landscape.

Investigators have found a new strain of methicillin-resistant Staphylococcus aureus (MRSA) transmitted by food. This strain could potentially be more easily transmitted from poultry to people, according to The Washington Post. The new strain reinforces the importance of limiting antibiotic use in livestock.

Despite widespread criticism, Mylan CEO, Heather Bresch, defended EpiPen’s price increase, and said the company does not plan to lower prices. She said in an appearance before the House Oversight and Government Reform Committee that the price and access of the drug are balanced, according to The New York Times. Panel members have said they want to explore new ways to create competition among epinephrine autoinjectors to drive prices down.

A government office could be in trouble after 6 of 8 investigators at the federal Office of Research Integrity have said they may leave, according to The Washington Post. The federal office examines misconduct such as falsification of data in biomedical research. The turmoil faced by employees can threaten the validity and quality of data published, and could even effect clinical trials in the long run.